AlphaQuest’s Charles River Laboratories CRL Stock Holding History

AlphaQuest’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,108	Closed	-$421K	–	479
2025 Q4	$421K	Buy	2,108 +84	+4%	+$15.2K	0.02%	959
2025 Q3	$317K	Sell	2,024 -402	-17%	-$63.8K	0.02%	1120
2025 Q2	$368K	Buy	+2,426	New	+$324K	0.04%	767
2024 Q4	–	Sell	-4	Closed	-$788	–	1758
2024 Q3	$788	Sell	4 -5,407	-100%	-$1.12M	﹤0.01%	1639
2024 Q2	$1.12M	Buy	5,411 +5,407	+135,175%	+$1.23M	0.15%	215
2024 Q1	$1.08K	Buy	+4	New	+$955	﹤0.01%	1376

Other funds holding CRL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AlphaQuest's CRL Position: Q1 2026 in Review

AlphaQuest sold out of Charles River Laboratories (CRL) in Q1 2026, closing a stake of 2,108 shares — an estimated $421K sold.

AlphaQuest first reported a position in CRL in Q1 2024 and held it in 6 quarters. The position peaked at $1.12M in Q2 2024. 560 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

AlphaQuest reported no remaining Charles River Laboratories position as of Q1 2026 after selling out during the quarter.
AlphaQuest sold 2,108 Charles River Laboratories shares in Q1 2026, an estimated $421K.
AlphaQuest first reported a position in Charles River Laboratories in Q1 2024 and held it in 6 quarters.
AlphaQuest's Charles River Laboratories position peaked at $1.12M in Q2 2024.
560 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.